Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
01 2Athena Pharmaceutiques
02 7Cohance Lifesciences
03 12Orion Corporation
04 26Granules India Limited
05 32care4
06 7Actavis Inc
07 1Adalvo
08 13Ajanta Pharma Limited
09 7Alkem Laboratories
10 7Alvogen
11 6Amneal Pharmaceuticals
12 20Apotex Inc
13 8Aristo Pharma GmbH
14 1Azurity Pharma
15 8Ebb Medical
16 7Elite Laboratories
17 1FrostPharma AB
18 1Frostpharma Ab
19 7Grindeks AS
20 7Hikma Pharmaceuticals
21 3Ideal Trade Links Uab
22 7JAMP PHARMA
23 7Lannett Company, Inc.
24 6MSN Laboratories
25 13Mallinckrodt Pharmaceuticals
26 6Medartuum
27 8ORIFARM GROUP AS
28 7PRO DOC LIMITEE
29 7Prinston
30 7RHODES PHARMACEUTICALS LP
31 12STADA Arzneimittel
32 23Sandoz B2B
33 6Spirig Healthcare
34 13Sun Pharmaceutical Industries Limited
35 80Takeda Pharmaceutical
36 6Taro Pharmaceutical Industries
37 37Teva Pharmaceutical Industries
38 7Viatris
01 6CAP
02 42CAPSULE
03 118CAPSULE;ORAL
04 116Capsule
05 30Hard Capsule
06 7Immediate Release Capsule
07 6Immediate Release Chewable Tablet
08 4Oral Solution
09 2Oral-Dispersible Tablet
10 1SOLUTION;ORAL
11 1Syrup
12 18TABLET (CHEWABLE)
13 42TABLET, CHEWABLE;ORAL
14 3capsule
15 10Blank
01 12Allowed
02 49Approved
03 2Authorised
04 16Authorized
05 60CONTROLLED DRUGS (CDSA I)
06 3Cancelled
07 22Deregistered
08 3Generic
09 22Marketed
10 3Not Marketed
11 3Originator
12 15Prescription
13 161RX
14 35Blank
01 7APO-LISDEXAMFETAMINE CAPSULES
02 6APO-LISDEXAMFETAMINE CHEWABLE TABLETS
03 1ARYNTA
04 6Adixel
05 6Adixemin
06 9Advancing
07 12Balidax
08 1DYSTRALEX 30
09 1DYSTRALEX 50
10 1DYSTRALEX 70
11 6Dexhility
12 47Elvanse
13 3Elvanse Adultos
14 14Elvanse Vuxen
15 7JAMP LISDEXAMFETAMINE
16 147LISDEXAMFETAMINE DIMESYLATE
17 6Lisdexamfetamin Orion Pharma
18 2Lisdexamfetamin Spirig HC
19 2Lisdexamfetamine
20 1Lisdexamfetamine Adalvo
21 1Lisdexamfetamine Aristo
22 13Lisdexamfetamine Dimesylate
23 6Lisdexamfetamine Orion
24 4Lisdexamfetamine Spirig HC
25 3Lisdexanfetamina Teva
26 7Manollia
27 3Offerlanz
28 7PRO-LISDEXAMFETAMINE
29 7SANDOZ LISDEXAMFETAMINE CAPSULES
30 1Silarosa
31 1Silaroza
32 6TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
33 7TEVA-LISDEXAMFETAMINE
34 26VYVANSE
35 6Volidax
36 6Vyvanse
37 1Vyvanse 30
38 1Vyvanse 50
39 1Vyvanse 70
40 14Blank
01 6Australia
02 60Canada
03 15Estonia
04 2France
05 20India
06 7Latvia
07 2Malta
08 25Norway
09 6South Africa
10 19Spain
11 71Sweden
12 12Switzerland
13 161USA
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
Regulatory Info :
Registration Country : France
Brand Name : Lisdexamfetamine
Dosage Form : Oral-Dispersible Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 20mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000140
Regulatory Info : Approved
Registration Country : Sweden
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2025-01-29
Application Number : 218987
Regulatory Info : RX
Registration Country : USA
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
Regulatory Info :
Registration Country : France
Brand Name : Lisdexamfetamine
Dosage Form : Oral-Dispersible Tablet
Dosage Strength : 70MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 70MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 30mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000157
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 40mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000164
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 50mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000171
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 60mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000188
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 70mg
Packaging :
Approval Date : 04/01/2024
Application Number : 20221130000195
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 20mg
Packaging :
Approval Date : 30/01/2023
Application Number : 20210831000115
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 30mg
Packaging :
Approval Date : 30/01/2023
Application Number : 20210831000122
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 40mg
Packaging :
Approval Date : 30/01/2023
Application Number : 20210831000139
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 50mg
Packaging :
Approval Date : 30/01/2023
Application Number : 20210831000146
Regulatory Info : Approved
Registration Country : Sweden
